FILTRES

Section de la LME

EN

FR

Liste modèle des médicaments essentiels

effacer Trouvé 11 recommandations pour 4 médicaments et 0 équivalent thérapeutique

Les médicaments retirés et les demandes rejetées ne sont pas indiqués. Les afficher.

8.2.5. Supportive medicines

Allopurinol Informations générales
Section

Supportive medicines

Oral > Solid: 100 mg; 300 mg
Indications

Tumour lysis syndrome
Mesna Informations générales
Section

Supportive medicines

Parenteral > General injections > IV: 100 mg per mL in 4 mL ampoule; 100 mg per mL in 10 mL ampoule

Oral > Solid: 400 mg; 600 mg
Indications

Osteosarcoma of bone and articular cartilage of other specified sites Other specified malignant neoplasms of the ovary Germ cell tumour of testis Ewing sarcoma of bone and articular cartilage of unspecified sites Rhabdomyosarcoma primary site Burkitt lymphoma including Burkitt leukaemia Malignant neoplasms of kidney, except renal pelvis
Rasburicase Informations générales
Section

Supportive medicines

Parenteral > General injections > IV: 1.5 mg in vial powder and solvent for solution; 7.5 mg in vial powder and solvent for solution
Indications

Tumour lysis syndrome
Zoledronic acid Informations générales
Section

Supportive medicines

Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle
Indications

Malignant neoplasm metastasis in bone or bone marrow